NGS performed on sections of a benign lymph node and the primary prostate tumor revealed a TP53 variant (c.215C>G; p.Pro72Arg; P72R; rs1042522), with a variant allele frequency of 47.06% in the benign tissue and 18.63% in the tumor. This evidence concerns the gene TP53 and neoplasm.